Dotmatics Brand Guidelines: Two Merck Scientists, GraphPad Prism & Siemens

Two Merck scientists and a 2005 start.

Dotmatics began as a project inside a drug company. In 2001, Genetic Engineering & Biotechnology News reported in 2018, Stephen Gallagher and Alastair Hill were working together at Merck in the United Kingdom on improving scientists’ access to data. Searching and sharing information across research projects was hard at the time, Gallagher recalled, and by 2005 the two had decided that what worked for them could work elsewhere. Rather than take part in a Merck spin-off, they left the company, acquired the rights to the technology they had been developing and founded Dotmatics. Gallagher told the magazine that in the earliest days they wrote code in a spare bedroom.

The UK company register supports the date: Companies House records Dotmatics Limited as incorporated in November 2005, with its registered office in Bishop’s Stortford, Hertfordshire. Gallagher became chief executive, and Hill was described in 2018 as director and chief technical officer and in 2021 as co-founder and chief information officer.

The aim, Gallagher said in 2018, was to build “scientifically aware tools” that let bench chemists and biologists capture, query and analyse their own data, and at first to serve small biotech companies without the resources of big pharma. About six months in, according to GEN, the Belgian drug company UCB became the first customer, licensing the first two products, Browser and Gateway, for hundreds of users; the University of Dundee and BioFocus followed. An electronic laboratory notebook came next. Gallagher recalled that early prospects liked the products but wondered whether the company would still be around in five years; in time, he said, companies began to seek it out. The 2018 profile also described the company’s push to let bench scientists run their own analyses without sending data to informatics specialists — what Gallagher called “coffee-break analytics.” By 2018 the company said it had a suite of 14 integrated tools and offices in eight countries, from the United States and the United Kingdom to Japan and South Korea.

Insightful Science, GraphPad Prism and a larger family.

For its first 16 years Dotmatics was a British software house. Hill said in 2021 that it had been able to scale its business and its products after a growth equity investment from Scottish Equity Partners. Then the ownership changed. On 23 March 2021, in a release datelined Bishop’s Stortford and San Diego, Insightful Science — a software group owned by the investment firm Insight Partners — announced a transaction to acquire Dotmatics, which it expected to close in the second quarter of that year, subject to regulatory clearances.

The deal joined Dotmatics’ enterprise platform, which the release described as cloud-based data management for scientific research across the life sciences, chemicals and materials industries, with a family of applications that individual researchers use at their desks. Insightful Science’s portfolio, the release said, included GraphPad Prism, the Geneious DNA-analysis tools and SnapGene, serving about a million scientists in universities, companies and government laboratories. Gallagher said the combination would let Dotmatics “strengthen our brand” as an enterprise informatics provider.

The applications now sit under the Dotmatics name. Its website lists them next to later additions such as LabArchives, OMIQ and Protein Metrics. Its newest platform is Luma, which Siemens described in 2025 as Dotmatics’ “Scientific Intelligence Platform.” The company’s own pages present Luma versions of Geneious and its flow-cytometry tools, and say its software is used by more than two million scientists in 125 countries — figures the company gives itself.

How the category presents itself.

Life-sciences software is sold to scientists, clinicians, regulators and procurement teams at once, and the way these companies present themselves reflects that mixed audience. Their websites and brochures tend to show clean dashboards on laptops and tablets, molecule renderings and data charts, and people in lab coats or at clinic desks looking at screens. The product, in other words, is usually shown as an interface rather than an object.

The colour schemes follow the same logic. Many of these brands set one or two bright product colours against a lot of white space, so that charts, buttons and status labels stand out, and they use plain sans-serif type that stays legible in dense tables. Product families are often split into named “clouds,” “suites” or “platforms,” each with its own sub-brand, so a single company can carry dozens of product names under one mark.

Much of the selling happens in person. The sector gathers at trade conferences such as the DIA Global Annual Meeting, which brings together people working on drug development and regulation; Bio-IT World, which focuses on data and computing in life-sciences research; and SLAS, the laboratory-automation and screening society’s conference. Larger vendors also run their own customer summits, with keynote stages, product launches and user sessions; Medidata, for example, says its NEXT conference grew out of a user group for its Rave software.

Ownership matters too: several of the companies in this round have changed hands, and some have been bought by larger groups while keeping their own names. The guides in this round set out who founded each company, who owns it now and what it makes, and they mark clearly which statements rest only on the company’s own word.

Siemens, Boston and Bishop’s Stortford.

The latest owner is an industrial group. On 2 April 2025, Dotmatics announced that it had signed a definitive agreement to be acquired by Siemens AG. In a release dated 1 July 2025 in Munich, Siemens said it had completed the acquisition of Dotmatics, which it described as headquartered in Boston and as a portfolio company of Insight Partners. Dotmatics became part of Siemens’ Digital Industries Software business, next to its product-lifecycle software, and Siemens said it would combine Dotmatics’ software with its “industrial AI technologies and digital twins.” Siemens presented the purchase as an expansion of its industrial software into the life sciences market, saying the combination would create a “connected digital thread” running from research through to production. The trade magazine Manufacturing Chemist reported the completion the following day.

The company registered in Bishop’s Stortford in 2005 is therefore now led from Boston as part of a German group, while keeping its own name. Its website still presents the brand and its products as Dotmatics, under the line “Harmonizing Science & Data to Create a Better Future, Together,” and describes a mission of connecting specialist applications on one open data platform for research laboratories.

For a design guide, Dotmatics shows how a small specialist brand can become the umbrella name for a much larger family of scientific software, including products that once sat under other company names. Compare Benchling, another research-software company, and Schrödinger, a drug-discovery software company. For this guide we use a deep green, a teal and a pale sage with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Dotmatics’s identity on hand — save it to a board in the Made Good inspiration library.